Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Left bundle branch area pacing with multimodal guidance vs. conventional pacing for heart failure with complete left bundle branch block

Official title: Clinical Efficacy and Safety of Left Bundle Branch Area Pacing Using Quantitative Guidance of Multimodal Data in the Treatment of Heart Failure: A Multicenter, Randomized Controlled Study

Run by Second Affiliated Hospital of Nanchang University · NCT07814612 · Data updated 2026-11-12

A multicenter trial tests whether using multimodal data to guide left bundle branch area pacing helps people with heart failure and complete left bundle branch block, compared with traditional biventricular pacing.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorSecond Affiliated Hospital of Nanchang University
Academic / other
Locations1 site (Nanchang, Jiangxi)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedSeptember 11, 2026
Trial IDNCT07814612 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-80 with non-ischemic cardiomyopathy, LVEF ≤40%, complete LBBB, sinus rhythm, NYHA II–IV, and on optimized heart failure therapy.

Probably not a fit

Patients with ischemic cardiomyopathy, non-LBBB conduction patterns, atrial fibrillation, or those needing pacemaker replacement without reimplantation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial compares multimodal quantitative guidance for left bundle branch area pacing to conventional biventricular pacing in adults with non-ischemic cardiomyopathy, reduced ejection fraction, and complete left bundle branch block. Participants receive guideline-directed medical therapy and are followed to assess long-term outcomes. The study aims to determine if the multimodal approach improves pacing effectiveness and safety, addressing limitations of current single-center and non-randomized evidence. Lead placement is guided by a predefined multimodal data fusion system, with intraoperative and postoperative recording of pacing parameters. The trial seeks to establish whether this physiological pacing strategy can achieve superior cardiac synchrony and clinical endpoints.

Why it matters

Potential benefit: If successful, patients could experience improved heart function, fewer symptoms, and potentially fewer hospitalizations.

How similar studies have gone: Previous studies on left bundle branch area pacing have shown promise but largely lack high-quality multicenter randomized evidence for long-term outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-80 years;
* Sinus rhythm, complete left bundle branch block (LBBB) fulfilling the Strauss criteria (QRS duration \>140 ms in men or \>130 ms in women);
* Non-ischemic cardiomyopathy, left ventricular ejection fraction (LVEF) ≤40%, and New York Heart Association (NYHA) functional class II-IV;
* Signed informed consent.
* All enrolled patients received guideline-recommended pharmacological therapy for heart failure for at least 3 months.

Exclusion Criteria:

* Coronary CT-confirmed ischemic cardiomyopathy;
* wide QRS complex with non-LBBB morphology, including right bundle branch block and nonspecific intraventricular conduction block;
* persistent atrial fibrillation;
* pacemaker replacement without reimplantation of ventricular leads;
* patients with special conditions, such as pregnancy, gestation, and advanced malignancy.
* All patients underwent detailed recording of electrophysiological pacing parameters intraoperatively and postoperatively, and monitoring for surgical complications.

Where it's running

  • Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
    Nanchang, Jiangxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.